Aminopterin/methotrexate embryofetopathy

Aminopterin/Methotrexate embryofetopathy is a syndrome of developmental anomalies characterized by growth deficiency, facial dysmorphism and skull, limb and neural defects secondary to maternal exposure to aminopterin or methotrexate (MTX) during pregnancy.

Also known as: aminopterin embryopathy syndrome, fetal aminopterin syndrome, foetal aminopterin syndrome, aminopterin fetopathy syndrome, aminopterin syndrome, fetal methotrexate syndrome, foetal methotrexate syndrome

0 clinical trials for this condition and its sub-types.